LYRA - Lyra Therapeutics GAAP EPS of -$5.51, revenue of $0.18M
2025-08-12 16:46:14 ET
More on Lyra Therapeutics
- Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst
- Lyra Therapeutics to raise up to $15M via registered direct offering and concurrent private placement, stock falls 22%
- Microcap Lyra Therapeutics surges 376% on phase 3 rhinosinusitis data
- Seeking Alpha’s Quant Rating on Lyra Therapeutics
- Historical earnings data for Lyra Therapeutics